This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy ...

As over half of Americans now receive prescriptions through Medicare or Medicaid, pharma companies must shift from a commercial-first approach to a statutory-first model, making GTN governance a ...

This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital ...

Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan ...